The Sept. 21 announcement states that Gadopiclenol Injection—a highly stable macrocyclic gadolinium-based contrast agent—is approved for use in adult and pediatric patients aged 2 years and older during MRI exams.

A total of 37,073 MRI examinations conducted at 552 facilities across the U.S. between January 2010 and March 2020 were included in the analysis.

According to the FDA’s most recent update, some presentations will remain out of stock or backordered until January 2023. 

The Aug. 29 statement indicates that non-radiologist physicians, advanced practice providers and registered nurses can oversee intravenous CT and MRI contrast administration at accredited imaging centers.

Here are the most popular stories on Health Imaging in August, based on our website analytics. 

A new consensus statement from the Society of Cardiovascular Computed Tomography emphasized the increasing importance of CCTA among interventional cardiologists. It is no longer seen as “a mere diagnostic tool," the group observed. 

The authors of the study hypothesized that they would find malalignments due to the nature of how the 2017 Fleischner Society guidelines, in that they do not pertain to incidentally detected nodules.

A new paper published in Academic Radiology highlights some of the key clinical education lessons derived from the many disruptions to radiology rotations during the height of COVID.